Big Cypress (BCYP) Shareholders Approve SAB Therapeutics Deal

big-cypress-sab logo

Big Cypress (BCYP) Shareholders Approve SAB Therapeutics Deal


Warning: DOMDocument::loadHTML(): Unexpected end tag : p in Entity, line: 5 in /var/convesio/wordpress/wp-content/plugins/spacinsider-upqode/src/Start.php on line 90

Big Cypress Acquisition Corp. (NASDAQ:BCYP) secured shareholder approval of its combination with clinical-stage biopharmaceutical company SAB Biotherapeutics in a special meeting held yesterday. Approximately 98.3% of the votes cast at the meeting, representing approximately 78.6% of Big Cypress’ outstanding shares, were cast in favor of the proposal to approve the business combination. The 8-K filing
Read More

To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.